BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17656188)

  • 41. [Spinal cord injuries. Autonomic dysfunction is to be documented according to standards].
    Karlsson AK
    Lakartidningen; 2009 Mar 11-17; 106(11):772-4. PubMed ID: 19418799
    [No Abstract]   [Full Text] [Related]  

  • 42. [Urination disorders and parkinson disease].
    Blanchard-Dauphin A
    Rev Neurol (Paris); 2009 Feb; 165 Spec No 1():F5-10. PubMed ID: 19623702
    [No Abstract]   [Full Text] [Related]  

  • 43. Optimizing therapeutic effects in patients with comorbidities: drug-resistant tremor, autonomic dysfunction, psychiatric disorders, and cognitive impairment.
    Chitnis S
    Neurol Clin; 2008 Aug; 26(3 Suppl):S29-44, v-vi. PubMed ID: 18774441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The management of the diabetic patient with renal disease.
    D'Elia JA; Kaldany A; Miller DG; Yoburn DC; Kaye WA; Weinrauch LA
    Compr Ther; 1984 Apr; 10(4):39-47. PubMed ID: 6373114
    [No Abstract]   [Full Text] [Related]  

  • 45. Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease.
    Pfeiffer RF
    Mov Disord; 2010; 25 Suppl 1():S94-7. PubMed ID: 20187255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
    Palma JA; Kaufmann H
    Mov Disord; 2018 Mar; 33(3):372-390. PubMed ID: 29508455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Peripheral autonomic insufficiency].
    Danilov AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(12):44-50. PubMed ID: 9591065
    [No Abstract]   [Full Text] [Related]  

  • 48. [Non-motor fluctuations in Parkinson's disease].
    Levin OS; Smolentseva IG; Ivanov AK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):90-6. PubMed ID: 20607929
    [No Abstract]   [Full Text] [Related]  

  • 49. Sleep issues in Parkinson's disease.
    Adler CH; Thorpy MJ
    Neurology; 2005 Jun; 64(12 Suppl 3):S12-20. PubMed ID: 15994219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory?
    Jamnadas-Khoda J; Koshy S; Mathias CJ; Muthane UB; Ragothaman M; Dodaballapur SK
    Mov Disord; 2009 Sep; 24(12):1747-51. PubMed ID: 19562759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurological disorders cerebrovascular disease and parkinsonism.
    Siroky MB
    Urol Clin North Am; 2003 Feb; 30(1):27-47, v. PubMed ID: 12580556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recognition and treatment of autonomic disturbances in Parkinson's disease.
    Li K; Reichmann H; Ziemssen T
    Expert Rev Neurother; 2015 Oct; 15(10):1189-203. PubMed ID: 26416396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut dysfunction in Parkinson's disease.
    Mukherjee A; Biswas A; Das SK
    World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Current therapeutic problems. Solutions].
    Castro García A; Sesar Ignacio A
    Neurologia; 1999 May; 14 Suppl 1():34-45. PubMed ID: 10377728
    [No Abstract]   [Full Text] [Related]  

  • 55. Nonmotor complications in Parkinson's disease.
    Adler CH
    Mov Disord; 2005; 20 Suppl 11():S23-9. PubMed ID: 15822106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-dopaminergic treatments in development for Parkinson's disease.
    Fox SH; Brotchie JM; Lang AE
    Lancet Neurol; 2008 Oct; 7(10):927-38. PubMed ID: 18848312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Digestive disorders in Parkinson's disease: dysphagia and sialorrhea].
    González-Fernández J; Prieto-Albin R; Velasco-Palacios L; Jorge-Roldán S; Cubo-Delgado E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S51-4. PubMed ID: 20205142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vesical-sphincter dysfunction in the Parkinsonism].
    Andrade MJ; Trêpa A
    Acta Med Port; 2003; 16(1):21-4. PubMed ID: 12828002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of non-motor symptoms in advanced Parkinson disease.
    Truong DD; Bhidayasiri R; Wolters E
    J Neurol Sci; 2008 Mar; 266(1-2):216-28. PubMed ID: 17804018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.